| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
GROWTH FACTORS-CYTOKINES-ONCOGENES |
Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
Address all correspondence and requests for reprints to: Dr. C.W.G.M. Löwik, Department of Endocrinology, Leiden University Medical Center, Building 1, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. E-mail: . c.w.g.m.lowik{at}lumc.nl
During bone formation and fracture healing there is a cross-talk between endothelial cells and osteoblasts. We previously showed that vascular endothelial growth factor A (VEGF-A) might be an important factor in this cross-talk, as osteoblast-like cells produce this angiogenic factor in a differentiation-dependent manner. Moreover, exogenously added VEGF-A enhances osteoblast differentiation. In the present study we investigated, given the coupling between angiogenesis and bone formation, whether bone morphogenetic proteins (BMPs) stimulate osteoblastogenesis and angiogenesis through the production of VEGF-A. For this we used the murine preosteoblast-like cell line KS483, which forms mineralized nodules in vitro, and an angiogenesis assay comprising 17-d-old fetal mouse bone explants that have the ability to form tube-like structures in vitro.
Treatment of KS483 cells with BMP-2, -4, and -6 enhanced nodule formation, osteocalcin mRNA expression, and subsequent mineralization after 18 d of culture. This was accompanied by a dose-dependent increase in VEGF-A protein levels throughout the culture period. BMP-induced osteoblast differentiation, however, was independent of VEGF-A, as blocking VEGF-A activity by a VEGF-A antibody or a VEGF receptor 2 tyrosine kinase inhibitor did not affect BMP-induced mineralization.
To investigate whether BMPs stimulate angiogenesis through VEGF-A, BMPs were assayed for their angiogenic activity. Treatment of bone explants with BMPs enhanced angiogenesis. This was inhibited by soluble BMP receptor 1A or noggin. In the presence of a VEGF-A antibody, both unstimulated and BMP-stimulated angiogenesis were arrested. Conditioned media of KS483 cells treated with BMPs also induced a strong angiogenic response, which was blocked by antimouse VEGF-A but not by noggin. These effects were specific for BMPs, as TGFß inhibited osteoblast differentiation and angiogenesis while stimulating VEGF-A production.
These findings indicate that BMPs stimulate angiogenesis through the production of VEGF-A by osteoblasts. In conclusion, VEGF-A produced by osteoblasts in response to BMPs is not involved in osteoblast differentiation, but couples angiogenesis to bone formation.
This article has been cited by other articles:
![]() |
D. M. Smadja, I. Bieche, J.-S. Silvestre, S. Germain, A. Cornet, I. Laurendeau, J.-P. Duong-Van-Huyen, J. Emmerich, M. Vidaud, M. Aiach, et al. Bone Morphogenetic Proteins 2 and 4 Are Selectively Expressed by Late Outgrowth Endothelial Progenitor Cells and Promote Neoangiogenesis Arterioscler. Thromb. Vasc. Biol., December 1, 2008; 28(12): 2137 - 2143. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kokubo, K. Nozaki, S. Fukushima, K. Takahashi, K. Miyata, R. Fujimoto, and S. Yokota Recombinant Human Bone Morphogenetic Protein-2 as an Osteoinductive Biomaterial and a Biodegradable Carrier in a Rabbit Ulnar Defect Model Journal of Bioactive and Compatible Polymers, July 1, 2008; 23(4): 348 - 366. [Abstract] [PDF] |
||||
![]() |
Y. Mifune, T. Matsumoto, A. Kawamoto, R. Kuroda, T. Shoji, H. Iwasaki, S.-M. Kwon, M. Miwa, M. Kurosaka, and T. Asahara Local Delivery of Granulocyte Colony Stimulating Factor-Mobilized CD34-Positive Progenitor Cells Using Bioscaffold for Modality of Unhealing Bone Fracture Stem Cells, June 1, 2008; 26(6): 1395 - 1405. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kotzsch, J. Nickel, A. Seher, K. Heinecke, L. van Geersdaele, T. Herrmann, W. Sebald, and T. D. Mueller Structure Analysis of Bone Morphogenetic Protein-2 Type I Receptor Complexes Reveals a Mechanism of Receptor Inactivation in Juvenile Polyposis Syndrome J. Biol. Chem., February 29, 2008; 283(9): 5876 - 5887. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.S. AI-Aql, A.S. Alagl, D.T. Graves, L.C. Gerstenfeld, and T.A. Einhorn Molecular Mechanisms Controlling Bone Formation during Fracture Healing and Distraction Osteogenesis J. Dent. Res., February 1, 2008; 87(2): 107 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Novicoff, A. Manaswi, M. V. Hogan, S. M. Brubaker, W. M. Mihalko, and K. J. Saleh Critical Analysis of the Evidence for Current Technologies in Bone-Healing and Repair J. Bone Joint Surg. Am., February 1, 2008; 90(Supplement_1): 85 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Pi, R. Ren, R. Kelley, C. Zhang, M. Moser, A. B. Bohil, M. DiVito, R. E. Cheney, and C. Patterson Sequential roles for myosin-X in BMP6-dependent filopodial extension, migration, and activation of BMP receptors J. Cell Biol., December 31, 2007; 179(7): 1569 - 1582. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Astorga and P. Carlsson Hedgehog induction of murine vasculogenesis is mediated by Foxf1 and Bmp4 Development, October 15, 2007; 134(20): 3753 - 3761. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Watanabe, H. Tsuchiya, K. Sakurakichi, and K. Tomita Bone transport using hydroxyapatite loaded with bone morphogenetic protein in rabbits J Bone Joint Surg Br, August 1, 2007; 89-B(8): 1122 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Scharpfenecker, M. van Dinther, Z. Liu, R.L. van Bezooijen, Q. Zhao, L. Pukac, C. W. G. M. Lowik, and P. ten Dijke BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis J. Cell Sci., March 15, 2007; 120(6): 964 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yao, A. F. Zebboudj, E. Shao, M. Perez, and K. Bostrom Regulation of Bone Morphogenetic Protein-4 by Matrix GLA Protein in Vascular Endothelial Cells Involves Activin-like Kinase Receptor 1 J. Biol. Chem., November 10, 2006; 281(45): 33921 - 33930. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Seeherman, K. Azari, S. Bidic, L. Rogers, X. J. Li, J. O. Hollinger, and J. M. Wozney rhBMP-2 Delivered in a Calcium Phosphate Cement Accelerates Bridging of Critical-Sized Defects in Rabbit Radii J. Bone Joint Surg. Am., July 1, 2006; 88(7): 1553 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. R. W. Simpson, L. Mills, and B. Noble The role of growth factors and related agents in accelerating fracture healing J Bone Joint Surg Br, June 1, 2006; 88-B(6): 701 - 705. [Full Text] [PDF] |
||||
![]() |
H. Seeherman, R. Li, M. Bouxsein, H. Kim, X. J. Li, E. A. Smith-Adaline, M. Aiolova, and J. M. Wozney rhBMP-2/Calcium Phosphate Matrix Accelerates Osteotomy-Site Healing in a Nonhuman Primate Model at Multiple Treatment Times and Concentrations J. Bone Joint Surg. Am., January 1, 2006; 88(1): 144 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Eckardt, M. Ding, M. Lind, E. S. Hansen, K. S. Christensen, and I. Hvid Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model J Bone Joint Surg Br, October 1, 2005; 87-B(10): 1434 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Langenfeld, J. Bojnowski, J. Perone, and J. Langenfeld Expression of Bone Morphogenetic Proteins in Human Lung Carcinomas Ann. Thorac. Surg., September 1, 2005; 80(3): 1028 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jadlowiec, D. Dongell, J. Smith, C. Conover, and P. Campbell Pregnancy-Associated Plasma Protein-A Is Involved in Matrix Mineralization of Human Adult Mesenchymal Stem Cells and Angiogenesis in the Chick Chorioallontoic Membrane Endocrinology, September 1, 2005; 146(9): 3765 - 3772. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Rajamannan, T. B. Nealis, M. Subramaniam, S. Pandya, S. R. Stock, C. I. Ignatiev, T. J. Sebo, T. K. Rosengart, W. D. Edwards, P. M. McCarthy, et al. Calcified Rheumatic Valve Neoangiogenesis Is Associated With Vascular Endothelial Growth Factor Expression and Osteoblast-Like Bone Formation Circulation, June 21, 2005; 111(24): 3296 - 3301. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ferrari, U. Pfeffer, R. Dell'Eva, C. Ambrosini, D. M. Noonan, and A. Albini The Transforming Growth Factor-{beta} Family Members Bone Morphogenetic Protein-2 and Macrophage Inhibitory Cytokine-1 as Mediators of the Antiangiogenic Activity of N-(4-Hydroxyphenyl)Retinamide Clin. Cancer Res., June 15, 2005; 11(12): 4610 - 4619. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Panopoulou, C. Murphy, H. Rasmussen, E. Bagli, E. K. Rofstad, and T. Fotsis Activin A Suppresses Neuroblastoma Xenograft Tumor Growth via Antimitotic and Antiangiogenic Mechanisms Cancer Res., March 1, 2005; 65(5): 1877 - 1886. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Bonnet and D. A. Walsh Osteoarthritis, angiogenesis and inflammation Rheumatology, January 1, 2005; 44(1): 7 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bostrom, A. F. Zebboudj, Y. Yao, T. S. Lin, and A. Torres Matrix GLA Protein Stimulates VEGF Expression through Increased Transforming Growth Factor-{beta}1 Activity in Endothelial Cells J. Biol. Chem., December 17, 2004; 279(51): 52904 - 52913. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ferrara Vascular Endothelial Growth Factor: Basic Science and Clinical Progress Endocr. Rev., August 1, 2004; 25(4): 581 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-S. Wang, C.-J. Wang, Y.-J. Chen, P.-R. Chang, Y.-T. Huang, Y.-C. Sun, H.-C. Huang, Y.-J. Yang, and K. D. Yang Ras Induction of Superoxide Activates ERK-dependent Angiogenic Transcription Factor HIF-1{alpha} and VEGF-A Expression in Shock Wave-stimulated Osteoblasts J. Biol. Chem., March 12, 2004; 279(11): 10331 - 10337. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.L. Murphy, C.A. Simmons, D. Kaigler, and D.J. Mooney Bone Regeneration via a Mineral Substrate and Induced Angiogenesis J. Dent. Res., March 1, 2004; 83(3): 204 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Langenfeld and J. Langenfeld Bone Morphogenetic Protein-2 Stimulates Angiogenesis in Developing Tumors Mol. Cancer Res., March 1, 2004; 2(3): 141 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dai, Y. Kitagawa, J. Zhang, Z. Yao, A. Mizokami, S. Cheng, J. Nor, L. K. McCauley, R. S. Taichman, and E. T. Keller Vascular Endothelial Growth Factor Contributes to the Prostate Cancer-Induced Osteoblast Differentiation Mediated by Bone Morphogenetic Protein Cancer Res., February 1, 2004; 64(3): 994 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Noel, D. Gazit, C. Bouquet, F. Apparailly, C. Bony, P. Plence, V. Millet, G. Turgeman, M. Perricaudet, J. Sany, et al. Short-Term BMP-2 Expression Is Sufficient for In Vivo Osteochondral Differentiation of Mesenchymal Stem Cells Stem Cells, January 1, 2004; 22(1): 74 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Langenfeld, S. E. Calvano, F. Abou-Nukta, S. F. Lowry, P. Amenta, and J. Langenfeld The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells Carcinogenesis, September 1, 2003; 24(9): 1445 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moser, O. Binder, Y. Wu, J. Aitsebaomo, R. Ren, C. Bode, V. L. Bautch, F. L. Conlon, and C. Patterson BMPER, a Novel Endothelial Cell Precursor-Derived Protein, Antagonizes Bone Morphogenetic Protein Signaling and Endothelial Cell Differentiation Mol. Cell. Biol., August 15, 2003; 23(16): 5664 - 5679. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Furumatsu, Z. N. Shen, A. Kawai, K. Nishida, H. Manabe, T. Oohashi, H. Inoue, and Y. Ninomiya Vascular Endothelial Growth Factor Principally Acts as the Main Angiogenic Factor in the Early Stage of Human Osteoblastogenesis J. Biochem., May 1, 2003; 133(5): 633 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Maeda, T. Kawane, and N. Horiuchi Statins Augment Vascular Endothelial Growth Factor Expression in Osteoblastic Cells via Inhibition of Protein Prenylation Endocrinology, February 1, 2003; 144(2): 681 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Valdimarsdottir, M.-J. Goumans, A. Rosendahl, M. Brugman, S. Itoh, F. Lebrin, P. Sideras, and P. ten Dijke Stimulation of Id1 Expression by Bone Morphogenetic Protein Is Sufficient and Necessary for Bone Morphogenetic Protein-Induced Activation of Endothelial Cells Circulation, October 22, 2002; 106(17): 2263 - 2270. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Street, M. Bao, L. deGuzman, S. Bunting, F. V. Peale Jr., N. Ferrara, H. Steinmetz, J. Hoeffel, J. L. Cleland, A. Daugherty, et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover PNAS, July 23, 2002; 99(15): 9656 - 9661. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |